Experience

• TravelClick, Inc. v. Variant Holdings, LLC, et al. (W.D.Wis.); Variant Holdings, LLC, et al. v. TravelClick, Inc. (E.D.Tex): Currently represent TravelClick in a series of litigations on multiple fronts concerning internet booking engines and e-commerce. The cases are at various stages of discovery with the earliest cases set for trial in late 2013. 
• Bayer HealthCare Pharmaceuticals, Inc. and Dow Pharmaceutical Sciences, Inc. v. River’s Edge Pharmaceuticals, LLC (N.D. Ga.): Currently represent plaintiffs in ANDA litigation concerning topical gel for the treatment of atopic dermatitis. Trial is scheduled for Spring 2014.
• Intendis GmbH et al. v. Glenmark Generics Ltd et al. (D.Del.): Currently represent plaintiffs in ANDA litigation concerning medication used to treat rosacea, acne and other skin irritations.
• Novartis Vaccines and Diagnostics Inc. v. Wyeth Pharmaceuticals, Inc. (E.D. Tex.): Represented Pfizer in a patent infringement case concerning recombinant Factor VIII protein used to treat hemophilia A patients. The case settled.
• SPRI Partners, LLC v. TravelClick, Inc. (N.D. Ill.): Currently represent TravelClick as lead counsel in a breach of contract/quasi-contract case concerning software and systems for TravelClick’s internet booking engine.
• Suzanne Jaffe Stillman v. Bayer HealthCare LLC, et al. (C.D. Cal.) Represented Bayer in a patent infringement action concerning dietary supplements containing fiber, water and “encapsulated” probiotics. The plaintiff voluntarily dismissed with prejudice all direct infringement claims after the court granted our motion to dismiss all claims for indirect infringement.
• Roche Diagnostics Operations Inc. and Corange Int’l. Ltd. v. Nova Biomedical Corp., et al (D.Del.): Currently represent Nova in a patent infringement case involving two patents relating to blood glucose test strips asserted by Roche Diagnostics.
• AstraZeneca LP et al. v. Breath Ltd., Apotex Corp and Apotex Inc., and Sandoz, Inc. (D.N.J.): Represented AstraZeneca in ANDA litigation and 7-week trial involving pediatric asthma drug, PULMICORT RESPULES®, and patents concerning methods of treatment and sterilized compositions.
• Merit Industries, Inc. v. JVL Corporation: Represented JVL over the course of a five-year case in which Merit alleged JVL’s entire product line infringed three Merit patents. A federal jury found that none of JVL’s current products infringed any Merit patent, invalidated many of the asserted claims and denied Merit’s demand for lost profits, awarding instead only a token sum (less than seven percent of what was sought) for reasonable royalties for infringement by a subset of JVL’s past products. 
• Analog Devices, Inc. v. Linear Technology Corporation; Represented Linear Technology in a patent infringement action relating to various patents on analog integrated circuitry. Along with denying that it had infringed any of Analog’s three asserted patents, our client counterclaimed for patent infringement based on eight of Linear’s U.S. patents.  We settled the matter favorably for our client.
• VLT, Inc. v. Lucent Technologies, Inc.: Represented Lucent in a patent infringement action concerning a patent related to voltage regulator circuits.  We settled the matter favorably for our client.